MATTIUZZI, Camilla
 Distribuzione geografica
Continente #
NA - Nord America 7.180
AS - Asia 5.402
EU - Europa 4.857
SA - Sud America 746
AF - Africa 137
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 10
Totale 18.351
Nazione #
US - Stati Uniti d'America 7.040
SG - Singapore 2.517
CN - Cina 1.320
GB - Regno Unito 1.256
RU - Federazione Russa 1.237
HK - Hong Kong 772
BR - Brasile 641
FR - Francia 456
IT - Italia 456
IE - Irlanda 390
DE - Germania 294
SE - Svezia 251
FI - Finlandia 206
KR - Corea 187
VN - Vietnam 156
UA - Ucraina 100
IN - India 86
CA - Canada 77
TG - Togo 60
TR - Turchia 50
ID - Indonesia 47
NL - Olanda 46
PK - Pakistan 46
BD - Bangladesh 31
JP - Giappone 30
MX - Messico 30
AR - Argentina 25
ES - Italia 25
AT - Austria 21
IQ - Iraq 18
IR - Iran 18
PL - Polonia 18
PE - Perù 16
PH - Filippine 15
MA - Marocco 14
ZA - Sudafrica 14
AU - Australia 13
IL - Israele 13
PY - Paraguay 13
TW - Taiwan 13
BE - Belgio 12
CO - Colombia 12
EC - Ecuador 11
RO - Romania 11
CH - Svizzera 10
CL - Cile 10
EG - Egitto 10
GR - Grecia 10
KE - Kenya 9
TH - Thailandia 9
BG - Bulgaria 8
CR - Costa Rica 8
DK - Danimarca 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
TN - Tunisia 7
UY - Uruguay 7
CZ - Repubblica Ceca 6
HR - Croazia 6
KZ - Kazakistan 6
MY - Malesia 6
PS - Palestinian Territory 6
TM - Turkmenistan 6
VE - Venezuela 6
AL - Albania 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
EU - Europa 5
LT - Lituania 5
PT - Portogallo 5
AZ - Azerbaigian 4
JO - Giordania 4
NG - Nigeria 4
NP - Nepal 4
NZ - Nuova Zelanda 4
PA - Panama 4
BZ - Belize 3
DZ - Algeria 3
LA - Repubblica Popolare Democratica del Laos 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CU - Cuba 2
GE - Georgia 2
HU - Ungheria 2
LV - Lettonia 2
NE - Niger 2
NO - Norvegia 2
OM - Oman 2
PR - Porto Rico 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
Totale 18.322
Città #
Dallas 1.552
Southend 1.015
Singapore 1.002
Hong Kong 755
Chandler 685
Jacksonville 561
Woodbridge 536
Ashburn 401
Dublin 385
Beijing 239
Ann Arbor 225
Houston 182
Lawrence 179
Princeton 179
Wilmington 160
Moscow 157
The Dalles 144
Redondo Beach 127
Buffalo 110
Kent 104
Los Angeles 100
Jinan 81
Nanjing 80
Columbus 79
Verona 79
London 75
New York 72
Shenyang 67
Milan 65
Lomé 60
Sindelfingen 58
Helsinki 54
Ho Chi Minh City 50
Tianjin 50
Seattle 49
São Paulo 49
Redwood City 47
Hebei 44
Fairfield 38
Santa Clara 38
Chicago 32
Changsha 31
Council Bluffs 31
Zhengzhou 31
Montreal 29
Jiaxing 28
Chennai 27
Haikou 27
Norwalk 27
Hanoi 26
Nanchang 26
Amsterdam 25
Rome 25
Tokyo 25
Munich 24
Boardman 23
Guangzhou 23
Lappeenranta 22
Rio de Janeiro 21
Washington 21
Hangzhou 20
Lahore 20
Taiyuan 20
Atlanta 19
San Francisco 17
Stockholm 17
Jakarta 16
Ningbo 16
Turku 16
Toronto 15
Warsaw 15
Belo Horizonte 14
Shanghai 14
Taizhou 14
Boston 13
Brooklyn 13
Mexico City 13
Phoenix 13
Vienna 13
Baltimore 12
Dearborn 12
Frankfurt am Main 12
Nuremberg 12
Secaucus 12
Seoul 12
Shenzhen 12
Falls Church 11
Fortaleza 11
Cambridge 10
Charlotte 10
Istanbul 10
Lanzhou 10
Paris 10
Redmond 10
Salvador 10
Tsuen Wan 10
Campinas 9
Da Nang 9
Dongguan 9
Florence 9
Totale 10.977
Nome #
Resurgence of cardiovascular disease mortality: a global and national infodemiological analysis of leading modifiable risk factors 280
Mortality Trends for Bacterial Septicaemia in the United States (1999–2024): Age, Sex Disparities and the Impact of the COVID-19 Pandemic 251
Variabilità preanalitica e Medicina di Laboratorio. 251
A Comparative Evaluation of the Chemiluminescence Immunoassay and ELISA for the Detection of Islet Autoantibodies in Type 1 Diabetes 191
C-reactive protein and migraine. Facts or speculations? 187
Atlante di Mortalità. Azienda ULSS n.1 di Belluno 171
The impact of the COVID-19 pandemic on diabetes-related mortality 153
Epidemiologia dei suicidi nel territorio della ULSS 21 (Regione Veneto) nel periodo 1989-1998 134
Managing the patient identification crisis in healthcare and laboratory medicine 132
Rising stroke mortality in the wake of COVID-19: unraveling the long-term impact of the pandemic on cerebrovascular health 132
Causes, consequences, detection, and prevention of identification errors in laboratory diagnostics. 123
Application of the new cholesterol guidelines. 122
Biological samples transportation by drones: ready for prime time? 121
Proposal of a checklist for venous blood collection. 120
Critical review and meta-analysis on the combination of heart-type fatty acid binding protein (H-FABP) and troponin for early diagnosis of acute myocardial infarction. 117
Laboratory preparedness to face infectious outbreaks. Ebola and beyond. 116
Are we getting better at the preanalytical phase or just better at measuring it? 116
Red meat consumption and ischemic heart disease. A systematic literature review. 115
Adiponectin and migraine: systematic review of clinical evidence. 112
BRCA population screening for predicting breast cancer: for or against? 111
Alcohol consumption and venous thromboembolism: friend or foe? 111
Prevention of doping in sports: epidemiological issues and ethical implications 110
Shifts in COVID-19 mortality throughout pandemic: a five-year analysis of healthcare responses. 110
Prostate-specific antigen (PSA) isoform p2PSA in prostate cancer screening: systematic review of current evidence and further perspectives. 108
Current epidemiology of low back pain 108
Critical review and meta-analysis of spurious hemolysis in blood samples collected from intravenous catheters. 106
Meat consumption and cancer risk: a critical review of published meta-analyses 106
Biomarker validation in the emergency department. General criteria and clinical implications. 105
Worldwide epidemiology and trends of adenosine diphosphate (ADP) receptor inhibitors usage 104
Prostate-Specific Antigen for Prostate Cancer Screening: A Different Strategy Should Be Planned. 103
Testing volume is not synonymous of cost, value and efficacy in laboratory diagnostics. 101
Gum-chewing and headache: an underestimated trigger of headache pain in migraineurs? 101
Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: A meta-analysis. 100
Epidemiologic burden of ischemic heart disease in Italy 100
Laboratory quality improvement by implementation of phlebotomy guidelines. 97
Overview on patient safety in healthcare and laboratory diagnostics. 97
Trends of popularity of cardiac biomarkers: Insights from Google Trends 97
Event reporting in laboratory medicine. Is there something we are missing? 96
New guidelines on treatment of blood cholesterol: too much of a good thing? 96
Red meat, processed meat and the risk of venous thromboembolism: Friend or foe? 95
Cardiovascular risk factors: updated worldwide population statistics 93
Smoking-related mortality in the United States. 92
Stat testing utilization in clinical laboratories. National survey of Italian Society of Clinical Biochemistry and Molecular Biology (SIBioC). 92
E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism. 92
Anti-doping testing: a moving target? 92
Are sniffer dogs a reliable approach for diagnosing SARS-CoV-2 infection? 91
Effect of melatonin supplementation on tinnitus: systematic literature review and meta-analysis 90
Preoperative laboratory testing 90
The challenges of evaluating scientists by H-index and citations in different biomedical research platforms. 90
Novel and emerging therapies: thrombus-targeted fibrinolysis. 90
Mean platelet volume in patients with ischemic heart disease: meta-analysis of diagnostic studies. 89
Point of care troponin testing: Rules and regulations. 89
Scientist impact factor (SIF): a new metric for improving scientists’ evaluation? 89
Cortisol and migraine. A systematic literature review 89
Oral anticoagulants around the world: an updated state-of-the art analysis 88
Pregnancy-associated plasma protein A (PAPP-A) for the early diagnosis of myocardial infarction: more doubts than certainties. 88
The biomarker paradigm: between diagnostic efficiency and clinical efficacy. 88
Direct oral anticoagulants: analysis of worldwide use and popularity using Google Trends 88
Worldwide epidemiology of carbon monoxide poisoning 88
Fried food consumption and ischemic heart disease. A systematic literature review. 88
Mandatory wearing of helmets for elite cyclists: new perspectives in prevention of head injuries. 87
Geographical trend of biomedical research: Analysis of a decade of publications in an "enlarged" Group of Eight (G8). 86
Screening for recreational drugs in sports. Balance between fair competition and private life. 86
Thrombophilia testing in patients taking direct oral anticoagulants. Handle with care. 86
Meat consumption and cancer risk: is the definition of red meat always suitable? 85
Association between climate and new daily diagnoses of COVID-19 85
Next Generation Antithrombotic Therapy: Focus on Antisense Therapy against Coagulation Factor XI. 84
Circulating microRNAs (miRs) for diagnosing acute myocardial infarction: Meta-analysis of available studies. 83
Severe Acute Respiratory Sindrome (SARS): una nuova ed intrigante sfida diagnostica. 82
Recenti sviluppi degli esami antidoping. Presupposti giuridici e ricadute pratiche. 82
Is body temperature mass screening a reliable and safe option for preventing COVID-19 spread? 82
Controlling sources of preanalytical variability in doping samples: challenges and solutions. 81
Scientific publishing in different countries: what simple numbers do not tell 81
Biological and epidemiologic updates on lip and oral cavity cancers 81
Combined administration of antibiotics and direct oral anticoagulants: a renewed indication for laboratory monitoring? 80
Patient and Sample Identification. Out of the Maze? 80
Ranking prestige of medical and laboratory technology journals. 79
Mean speed in professional cycling: No evidence of decline. 79
Legal regulation and medico-forensic aspects of the current anti-doping legislation. 78
Measuring the potential impact of physical inactivity on worldwide epidemiology of colorectal and breast cancers 78
Cancer statistics: a comparison between World Health Organization (WHO) and Global Burden of Disease (GBD) 78
Pistorius ineligible for the Olympic Games: the right decision. 77
Nuove realtà in politica sanitaria: benchmarking e laboratorio clinico. 77
MicroRNAs for diagnosing myocardial infarction. Advantages and limitations. 77
No Evidence for an Association of Vitamin D Deficiency and Migraine: A Systematic Review of the Literature. 77
Chocolate and migraine: the history of an ambiguous association. 77
The impact of seasonality and other determinants on vitamin D concentration in childhood and adulthood: still an unresolved issue. 77
Current Cancer Epidemiology 77
Concise guide to coronavirus disease 2019 (COVID-19) diagnostics 77
Estimating the worldwide burden of COVID-19 related anosmia and ageusia 76
Benzodiazepines consumption may have increased during the COVID-19 pandemic 76
Migraine and erythrocyte biology: a review. 76
Recent updates on worldwide gout epidemiology 76
Clinical laboratories and infectious outbreak emergencies: Ebola and beyond [I laboratori clinici nell'emergenza dei focolai epidemici infettivi: Ebola e oltre] 75
More pistachio nuts for improving the blood lipid profile. Systematic review of epidemiological evidence 75
No correlation between health care expenditure and mortality in the European Union 75
Fish Intake and Venous Thromboembolism: A Systematic Literature Review 75
Updates on larynx cancer epidemiology 75
Analysis of Google Searches for COVID-19 and its symptoms for predicting disease epidemiology in the United States 75
Homocysteine and migraine. A narrative review. 75
Totale 10.070
Categoria #
all - tutte 79.251
article - articoli 75.460
book - libri 503
conference - conferenze 572
curatela - curatele 0
other - altro 263
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.453
Totale 158.502


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021616 0 0 0 0 161 169 13 45 41 13 128 46
2021/2022929 96 152 7 14 28 33 23 61 84 51 106 274
2022/20232.350 202 92 278 374 227 594 14 156 275 21 79 38
2023/20241.432 60 95 89 133 144 186 130 98 34 85 289 89
2024/20254.902 283 367 354 636 247 107 188 291 705 360 439 925
2025/20265.093 1.078 976 1.410 1.549 80 0 0 0 0 0 0 0
Totale 18.839